ADC Therapeutics SA Quarterly Depreciation in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ADC Therapeutics SA quarterly/annual Depreciation history and growth rate from Q1 2023 to Q3 2024.
  • ADC Therapeutics SA Depreciation for the quarter ending September 30, 2024 was $336K, a 6.33% increase year-over-year.
  • ADC Therapeutics SA Depreciation for the twelve months ending September 30, 2024 was $1.33M.
  • ADC Therapeutics SA annual Depreciation for 2023 was $1.19M, a 12% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.33M $336K +$20K +6.33% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.31M $326K +$53K +19.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.26M $331K +$68K +25.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.19M $335K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $316K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $273K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $263K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.